Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer. | Cancer Res | 2022 | 35131873 | PubTator, text mining | PubMed |
| Construction of a Prognosis-Related Gene Signature by Weighted Gene Coexpression Network Analysis in Ewing Sarcoma. | Comput Math Methods Med | 2022 | 35126643 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer. | Medicine (Baltimore) | 2022 | 35119046 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| On the role of phase separation in the biogenesis of membraneless compartments. | EMBO J | 2022 | 35107832 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals. | Mol Cancer | 2022 | 35090471 | PubTator, text mining | PubMed |
| Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer. | J Oncol | 2022 | 35087589 | PubTator, text mining | PubMed |
| Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response. | J Biol Chem | 2022 | 35085551 | PubTator, text mining | PubMed |
| BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis. | Bioengineered | 2022 | 35068350 | PubTator, text mining | PubMed |
| Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma. | J Biomed Sci | 2022 | 35062934 | PubTator, text mining | PubMed |
| Tumor microenvironment-related multigene prognostic prediction model for breast cancer. | Aging (Albany NY) | 2022 | 35060926 | PubTator, text mining | PubMed |
Hypoxia induces radioresistance, epithelial‑mesenchymal transition, cancer stem cell‑like phenotype and changes in genes possessing multiple biological functions in head and neck squamous cell carcinoma. | Oncol Rep | 2022 | 35059742 | PubTator, text mining | PubMed |
| Biallelic BUB1 mutations cause microcephaly, developmental delay, and variable effects on cohesion and chromosome segregation. | Sci Adv | 2022 | 35044816 | Swiss-Prot, curated | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
| Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis. | Cancer Cell Int | 2022 | 35033076 | PubTator, text mining | PubMed |
| USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1. | Cell Death Discov | 2022 | 35027535 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies. | Int J Oncol | 2022 | 35014681 | PubTator, text mining | PubMed |
| LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma. | Genes Dis | 2022 | 35005115 | PubTator, text mining | PubMed |
| In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. | Gene | 2022 | 34995734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=41